Cognitive
NA-Selank-Amidate
Also called N-Acetyl Selank Amidate
per administration
The amounts going around come from sellers and forums, not from any study.
The human evidence for NA-Selank-Amidate used the intranasal route. The draw worked out here assumes a subcutaneous injection, so the amount is not a direct read-across.
Work out your draw
These numbers are a starting point — change any of them.
- Concentration
- 1.67mg/mL
- Volume per draw
- 0.06mL
- Units to dial
- 6
- Doses per cartridge
- 50
Vial label
Copy this into your label printer.
Published research contexts for NA-Selank-Amidate describe 100–300 mcg per administration. Descriptive only, not a recommendation.
The N-terminal acetyl and C-terminal amide slow peptidase degradation relative to Selank, but human pharmacokinetics are essentially unpublished, so read this as order-of-magnitude only.
A terminally modified Selank analog. Circulating amounts come from vendor listings and community write-ups rather than any published dose-ranging work, and no human trial of its own fixes an amount or schedule, so no schedule table is shown.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 5hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Modified-Selank / neuropeptide community literatureThe N-acetyl amidated analog has no published human dose-ranging trial; figures trace to vendor listings and community reports.